[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557410":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":17,"armGroups":13,"interventions":13,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":53,"collaborators":13,"id":55,"slug":13,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":13,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":13,"enrollmentInfo":63,"targetDuration":13,"studyType":66,"phases":13,"briefSummary":67,"conditions":68,"keywords":13,"overallStatus":27,"whyStopped":13,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Boryung Pharmaceutical Co., Ltd","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Incidence of ethanol-induced symptoms in the initial cycle","This outcome's definition is an increase from baseline in the number of ethanol-induced symptoms during or within 30 minutes after the treatment. The initial cycle of non-ethanol formulation docetaxel is collected as 1 cycle.","From the time of treatment started until the end of follow-up(30 minutes after the treatment)",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"COHORT","PROSPECTIVE","Breast cancer patients in need of neoadjuvant\u002Fadjuvant chemotherapy including Non-ethanol formulation docetaxel before and after surgery",[19],{"name":20,"role":21,"phone":22,"phoneExt":13,"email":23},"Shin-young Oh","CONTACT","+82-2-708-8000","syoh@boryung.co.kr",[25,40],{"facility":26,"status":27,"city":28,"state":13,"zip":29,"country":30,"countryCode":13,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Chung-Ang University Hospital","RECRUITING","Seoul","06973","South Korea",{"type":32,"coordinates":33},"Point",[34,35],126.9784,37.566,{"lat":35,"lon":34},[38],{"name":39,"role":21,"phone":13,"phoneExt":13,"email":13},"Min Kyoon Kim",{"facility":41,"status":42,"city":43,"state":13,"zip":44,"country":30,"countryCode":13,"cosmosGeoPoint":45,"geoPoint":49,"contacts":50},"Uijeongbu Eulji Medical Center, Eulji University","NOT_YET_RECRUITING","Uijeongbu-si","11759",{"type":32,"coordinates":46},[47,48],127.0474,37.7415,{"lat":48,"lon":47},[51],{"name":52,"role":21,"phone":13,"phoneExt":13,"email":13},"Byung Joo Song",{"type":54,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100557410",false,"NCT06537752","A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients","A Multi-center, Prospective, Observational stuDy to Evaluate EThanOl-induced Symptoms and Safety in Breast Cancer Patients witH Neoadjuvant\u002FAdjuvant Chemotherapy Including Non-ethanol Formulation Docetaxel Before and After Surgery","Inclusion Criteria:\n\n* Those who voluntarily signed a written personal information collection and usage agreement after receiving an explanation about the objective and method, etc. of this clinical study.\n* Those are confirmed to have primary breast cancers through histological diagnosis and one of the following are applicable.\n\n  * Those who need neoadjuvant chemotherapy as breast cancer patients\n  * Those who need adjuvant chemotherapy after breast cancer surgery\n* Those who are scheduled to administer non-ethanol formulation docetaxel according to chemotherapy\n* Those able to understand this study, be cooperative in the execution of the study, and participate in the study until its completion.\n\nExclusion Criteria:\n\n* Those are diagnosed with other primary cancer that can influence the treatment or prognosis of primary breast cancers.\n* Those are diagnosed with secondary breast cancers.\n* Those with Stage 0\u002F1 (Tis, N0, M0) or Stage IV (any T, Any N, M1) breast cancers.","FEMALE","19 Years",{"count":64,"type":65},1052,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate ethanol-induced symptoms and safety in breast cancer patients with neoadjuvant\u002Fadjuvant chemotherapy including Non-ethanol formulation docetaxel before and after surgery",[69],"Breast Cancer","2025-09-10",{"date":72,"type":73},"2025-09-12","ACTUAL",{"date":75,"type":73},"2024-07-15",{"date":77,"type":65},"2026-10",{"name":5,"class":6},2]